In the case of obesity, it comes with a series of endocrine and metabolic disorders that cause several gynecological alterations, including, but not limited to, hyperandrogenism (androgen excess), hyperinsulinism, and anovulation. In the case of anovulation, when a woman is undergoing a fertility treatment, it means longer ovarian stimulation protocols, higher doses of gonadotropins, higher drop-out rates due to poor ovarian response, lower implantation and pregnancy rates, and an increased miscarriage rate.
How does obesity influence the outcomes of fertility treatments?
By Javier Domingo del Pozo M.D., Ph.D. (gynecologist).
Last Update: 11/10/2014
Javier Domingo del Pozo
Bachelor's Degree in Medicine from the University of Alicante. Specialist in Obstetrics & Gynecology via M. I. R. at Hospital Universitario Materno-Infantil of Canarias, Spain. PhD in Human Reproduction and Female Reproductive System Pathology from the University of Las Palmas de Gran Canaria. Currently, he is the Director of the clinics IVI Las Palmas and IVI Tenerife.